Related studies have demonstrated that GLP-1R activation upregulates in situ expression of fibroblast growth factor-7 (FGF7) in intestinal tumor cells, promoting tumor progression and inducing intestinal hyperplasia. Here, FGF7 is linked to intestinal neoplasm.